跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22,325 条关于
“GCS inhibitor”
全部
22,325
临床试验
11,484
药物
4,615
机构
87
资讯
6,139
去年
AceLink's Oral GCS Inhibitor Shows Promising Phase 2 Results in Fabry Disease Treatment
去年
AceLink Therapeutics' AL01211 Shows Promising Safety and Biomarker Reduction in Phase 2 Fabry Disease Trial
去年
Systematic Review Questions Impact of Genomic Classifier Tests in Prostate Cancer Treatment Decisions
9个月前
RedHill's Opaganib Shows Promise in Overcoming Venetoclax Resistance in Chronic Lymphocytic Leukemia
去年
Early Control of Rheumatoid Arthritis Improves Hemostatic Imbalance
去年
Gilteritinib Shows Promise as ALK Inhibitor in Acute Myeloid Leukemia
去年
RedHill Biopharma Secures U.S. Patent for Opaganib Biomarker in COVID-19 Treatment
去年
ACCESS-GC Trial Integrates Genetic Counselors into Primary Care in British Columbia
去年
RedHill and Bayer Launch Phase 2 Trial Combining Opaganib with Darolutamide for Advanced Prostate Cancer
2年前
Merck's Bomedemstat Shows Promise as Irreversible LSD1 Inhibitor for MPNs
第 1 页,共 614 页
上一页
下一页